Featured Research

from universities, journals, and other organizations

Cross Talk Between Bacteria, Host Leads To E. Coli Infection

Date:
July 3, 2003
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
A strain of E. coli that causes severe, sometimes deadly, intestinal problems relies on signals from beneficial human bacteria and a stress hormone to infect human cells, a researcher at UT Southwestern Medical Center at Dallas has discovered.

DALLAS (June 30, 2003) – A strain of E. coli that causes severe, sometimes deadly, intestinal problems relies on signals from beneficial human bacteria and a stress hormone to infect human cells, a researcher at UT Southwestern Medical Center at Dallas has discovered.

The finding, which will appear online today in Proceedings of the National Academy of Sciences, could lead to the development of beta blockers as a therapy to impede this cellular signaling system, causing the harmful bacteria to pass blindly through the digestive tract, said Dr. Vanessa Sperandio, lead author of the study.

"You're not really attacking the bacteria per se," said Dr. Sperandio, assistant professor of microbiology at UT Southwestern. "You are just rendering it blind. The bacteria won't activate the virulent genes unless it knows where it is. If it can't activate the things it needs to bind to the intestine, it will be washed away."

In the past, beta blockers have been used to treat migraines, high blood pressure, glaucoma and tremors but not to impede infection. Developing new therapies for infection with this strain of E. coli – known as enterohemorrhagic Escherichia coli, or EHEC – is important because treatment with conventional antibiotics can cause the release of more toxins and may worsen the disease outcome.

Dr. Sperandio found that when a person ingests EHEC, the bacteria travel blindly through the digestive tract until reaching the intestine, where friendly bacterial flora in the intestine and the human hormone epinephrine, or adrenaline, send cellular signals alerting the bacteria to its location. This cellular cross talk leads to a cascade of genetic activations in which the EHEC colonizes the intestine and translocates toxins into human cells, altering the makeup of the cells and robbing the body of nutrients.

"The bacteria gets what it wants – nourishment - and the person ends up getting diarrhea," Dr. Sperandio said.

EHEC is responsible for outbreaks throughout the world of bloody diarrhea and hemolytic uremic syndrome – a condition that can lead to renal failure and death. Severe symptoms are most common in children, the elderly and immune-suppressed people.

EHEC is commonly transmitted through contaminated food or water. Foods known to have caused human infections include raw meat and unwashed vegetables. The Centers for Disease Control and Prevention report 73,000 cases of EHEC infection annually in the United States, resulting in 61 deaths.

Bloody diarrhea typically lasts about a week after infection with E. coli. One week after the condition resolves, some patients may develop hemolytic uremic syndrome, which is characterized by gastrointestinal bleeding, reduced urine production and anemia.

Treating EHEC infection with conventional antibiotics has shown to increase the chances that a patient will develop hemolytic uremic syndrome, Dr. Sperandio said. In 2000, an EHEC outbreak in Scotland affected thousands of people. Half of those infected received antibiotics, and half received no therapy. Of those treated with antibiotics, 18 percent developed the syndrome; of those receiving no treatment, only 5 percent developed the syndrome.

Dr. Sperandio, a Brazilian native whose studies focus mainly on gene regulation, began this three-and-a-half-year study during a postdoctoral fellowship at the University of Maryland School of Medicine. Other authors of the study included University of Maryland researchers.

The work was funded in part by the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "Cross Talk Between Bacteria, Host Leads To E. Coli Infection." ScienceDaily. ScienceDaily, 3 July 2003. <www.sciencedaily.com/releases/2003/07/030701223433.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2003, July 3). Cross Talk Between Bacteria, Host Leads To E. Coli Infection. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2003/07/030701223433.htm
University Of Texas Southwestern Medical Center At Dallas. "Cross Talk Between Bacteria, Host Leads To E. Coli Infection." ScienceDaily. www.sciencedaily.com/releases/2003/07/030701223433.htm (accessed August 20, 2014).

Share This




More Plants & Animals News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Newsy (Aug. 19, 2014) Scientists have developed a new device that mimics the way octopuses blend in with their surroundings to hide from dangerous predators. Video provided by Newsy
Powered by NewsLook.com
Disquieting Times for Malaysia's 'fish Listeners'

Disquieting Times for Malaysia's 'fish Listeners'

AFP (Aug. 19, 2014) Malaysia's last "fish listeners" -- practitioners of a dying local art of listening underwater to locate their quarry -- try to keep the ancient technique alive in the face of industrial trawling and the depletion of stocks. Duration: 02:29 Video provided by AFP
Powered by NewsLook.com
USDA Cracks Down On Imports From Foreign Puppy Mills

USDA Cracks Down On Imports From Foreign Puppy Mills

Newsy (Aug. 18, 2014) New USDA measures to regulate dog imports aim to crack down on buying dogs from overseas puppy mills. Video provided by Newsy
Powered by NewsLook.com
Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Newsy (Aug. 18, 2014) Researchers performed an experiment using an FDA-approved drug known as ruxolitinib. They found it to be successful in the majority of patients. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins